Ametek Stock Earnings Reports

AMETEK reported a very strong Q3 2025: record sales of $1.89B (up 11%), record orders of $1.97B (up 13%) and a record backlog of $3.54B. Organic sales grew 4% in the quarter with acquisitions contributing meaningfully (+6 points). Operating income, EBITDA and diluted EPS all reached records with notable margin expansion (EBITDA margin 31.3%; operating margins improved across both EIG and EMG). Management raised full-year EPS guidance to $7.32–$7.37 (up ~7–8% vs. 2024) and expects Q4 sales to be up ~10% with EPS of $1.90–$1.95. Cash generation was strong (Q3 operating cash flow $441M; free cash flow $420M; FCF conversion ~113% in the quarter and guidance of ~110–115% for the year). Balance sheet remains conservative (total debt $2.5B; gross leverage ~1x; net leverage ~0.9x) with >$2B of cash and available credit. Strategic M&A remains a core element of growth — recent acquisitions (FARO, Virtek, Kern, Paragon) are integrating well — and management continues to pursue targets while also increasing organic investment by ~$90M for R&D, sales and digital marketing. Segment takeaways: EIG delivered high margins with flat organic sales, EMG posted strong organic growth (EMG organic +12%) and large margin improvement, A&D remains robust with low-double-digit organic growth in the quarter, Power & Industrial showed improving demand tied to grid modernization and data-center/microgrid opportunities, and Process is improving outside China despite trade/tariff-related timing delays. Key risks flagged: ongoing trade/tariff dynamics (notably China) that can delay orders and decision timing.